ResMed Inc. (VIE:RMD)

Market Cap	31.00B -8.4%
Revenue (ttm)	4.60B +9.6%
Net Income	1.27B +19.0%
EPS	8.61 +19.4%
Shares Out	n/a
PE Ratio	24.50
Forward PE	21.66
Dividend	2.01 (0.95%)
Ex-Dividend Date	Nov 13, 2025

Volume	n/a
Average Volume	3
Open	212.60
Previous Close	215.80
Day's Range	212.60 - 213.50
52-Week Range	181.80 - 251.50
Beta	n/a
RSI	50.29
Earnings Date	Jan 29, 2026

About ResMed

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1989
• Employees: 10,600
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: RMD

Financial Performance

In fiscal year 2025, ResMed's revenue was $5.15 billion, an increase of 9.84% compared to the previous year's $4.69 billion. Earnings were $1.40 billion, an increase of 37.20%.

Financial numbers in USD